ReviewMolecular biomedicine2026
Craniofacial development: genetics, signaling pathways, teratogenic mechanisms, and clinal significance.
Review in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Craniofacial development is a highly coordinated and stage-specific process involving neural crest cell migration, proliferation, differentiation, and epithelial-mesenchymal transition. Genetic mutations, signaling pathway abnormalities, and exposure to environmental teratogens can disrupt normal development. These anomalies can lead to cleft palate, craniosynostosis, and other common congenital craniofacial malformations. Although significant progress has been made in understanding craniofacial development in recent years, the systematic integration of these factors remains limited. Here, we provide a comprehensive review of the cellular and molecular mechanisms underlying normal craniofacial development, focusing on the coordinated regulation of cranial neural crest cells by transcription factors, signaling pathways and epigenetic programs. We further summarize major pathogenic mechanisms implicated in craniofacial disorders. Additionally, the teratogenic mechanisms underlying maternal endogenous and external environmental exposures are explored, with particular emphasis on their interactions with genetic factors in reshaping developmental trajectories. We emphasize the central role of gene-environmental interactions in craniofacial pathogenesis by integrating evidence from developmental biology, multi-omics studies and clinical studies. Subsequently, we outline current clinical diagnostic techniques and management strategies for craniofacial malformations, pointing out the existing challenges and future directions. This review establishes a comprehensive framework linking gene regulation, metabolic environment, and clinical implications. It is expected to facilitate deeper insights into disease mechanisms and promoting the translation of basic research findings into clinical diagnosis, prevention, and management of craniofacial disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.